| Kendra S James, CRNA | |
|
520 S Santa Fe Ave, Ste 260, Salina, KS 67401-4190 | |
| (785) 827-2238 | |
| (785) 827-1684 |
| Full Name | Kendra S James |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 520 S Santa Fe Ave, Salina, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235190422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 55018 (Kansas) | Primary |
| Entity Name | Newton Anesthesia Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669443172 PECOS PAC ID: 7214923721 Enrollment ID: O20040421001051 |
News Archive
Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.
Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die. Now researchers at Washington University School of Medicine in St. Louis have found an efficient way to get a messenger into cancer cells that forces them to respond to death signals. And they did it using one of the most sinister pathogens around - HIV.
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
› Verified 1 days ago
| Entity Name | Kansas Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380127 PECOS PAC ID: 2668476862 Enrollment ID: O20061109000659 |
News Archive
Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.
Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die. Now researchers at Washington University School of Medicine in St. Louis have found an efficient way to get a messenger into cancer cells that forces them to respond to death signals. And they did it using one of the most sinister pathogens around - HIV.
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
› Verified 1 days ago
| Entity Name | Clinical Colleagues Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992725766 PECOS PAC ID: 8729011333 Enrollment ID: O20080514000425 |
News Archive
Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.
Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die. Now researchers at Washington University School of Medicine in St. Louis have found an efficient way to get a messenger into cancer cells that forces them to respond to death signals. And they did it using one of the most sinister pathogens around - HIV.
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
› Verified 1 days ago
| Entity Name | Kansas Spine Anesthesia Corporation Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720345911 PECOS PAC ID: 1153586821 Enrollment ID: O20120702000174 |
News Archive
Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.
Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die. Now researchers at Washington University School of Medicine in St. Louis have found an efficient way to get a messenger into cancer cells that forces them to respond to death signals. And they did it using one of the most sinister pathogens around - HIV.
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendra S James, CRNA 520 S Santa Fe Ave, Ste 260, Salina, KS 67401-4190 Ph: (785) 827-2238 | Kendra S James, CRNA 520 S Santa Fe Ave, Ste 260, Salina, KS 67401-4190 Ph: (785) 827-2238 |
News Archive
Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.
Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die. Now researchers at Washington University School of Medicine in St. Louis have found an efficient way to get a messenger into cancer cells that forces them to respond to death signals. And they did it using one of the most sinister pathogens around - HIV.
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
› Verified 1 days ago
Christina Thongphanh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mrs. Melinda Trogstad, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mr. Hugh J Hyberger, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 520 S Santa Fe Ave, Suite 260, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Anne Njoki Njoroge, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Shannon Mawyin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 520 S Santa Fe Ave, 260, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Andrew Edward Pecore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mr. Christopher John Schroeder, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 |